Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.71 |
| ▸ | AIMP2 | Q13155 | 5/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 3/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18997644 | 0.86 | MTNR1A (0.66) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL19049397 | 0.86 | MTNR1A (0.66) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL21416050 | 0.83 | MTNR1A (0.70) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL21348630 | 0.83 | MTNR1A (0.70) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL15526245 | 0.83 | AIMP2 (0.59) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL15526246 | 0.83 | AIMP2 (0.59) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL15526244 | 0.83 | AIMP2 (0.59) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL7202212 | 0.83 | MTNR1A (1.00) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL17656930 | 0.83 | AIMP2 (0.49) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL25337575 | 0.82 | AIMP2 (1.00) | MTNR1AAIMP2CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174699-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | MAPK6, MAP3K6, MAPK4 | MTNR1A 1704/4885AIMP2 4338/4885CYP1A2 4411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.